Advertisement

The Scientist

» drug development, immunology and ecology

Most Recent

image: Screening Goes In Silico

Screening Goes In Silico

By | February 1, 2015

Computational tools take some of the cost—and guesswork—out of drug discovery.

0 Comments

image: Stubbornly Persistent

Stubbornly Persistent

By | February 1, 2015

Microorganisms continually challenge our assumptions of what life can achieve.

1 Comment

image: Thanks for the Memories

Thanks for the Memories

By | February 1, 2015

B and T cells may be the memory masters of the immune system, but research reveals that other cells can be primed by pathogens, too.

1 Comment

image: Viral Virtuosos

Viral Virtuosos

By | February 1, 2015

New understanding of noncoding RNAs may solve a long-standing puzzle about how viruses orchestrate lifelong infections.  

3 Comments

image: Drug Stimulates Brown Fat

Drug Stimulates Brown Fat

By | January 28, 2015

A small study finds that an approved medication increases metabolic rate and the activity of thermogenic brown fat in men.

2 Comments

image: Interferon Discoverer Dies

Interferon Discoverer Dies

By | January 26, 2015

Jean Lindemann, the virologist who helped figure out that interferons were responsible for anti-viral responses, has passed away at age 90.

0 Comments

image: Inflammation Overdrive

Inflammation Overdrive

By | January 15, 2015

Experimental vaccines that specifically boost T helper cells lead to immunopathology and death in mice.

2 Comments

image: IOM Urges Data Sharing

IOM Urges Data Sharing

By | January 15, 2015

The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.

0 Comments

image: Shire Makes $5.2 Billion Buy

Shire Makes $5.2 Billion Buy

By | January 13, 2015

The Irish drugmaker moves on from its terminated sale to AbbVie to purchase New Jersey-based NPS Pharmaceuticals.

0 Comments

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

Popular Now

  1. Opinion: Making Progress by Slowing Down
  2. How Fats Influence the Microbiome
  3. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  4. Influential Cancer Biologist Dies
Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement